Over the past decade, numerous studies have identified the association of elevated C-reactive protein (CRP) levels with poor outcomes, mortality, and hemorrhagic transformation (HT) [10,11], while neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are correlated with neurological deterioration, post-stroke pneumonia, and unfavorable functional outcomes [12,13]. The gene discussed is CRP; the disease is hematocrit.